Medical Economics October 22, 2024
Key Takeaways
- CareIntellect for Oncology uses AI to consolidate patient data, enhancing decision-making efficiency for clinicians.
- The platform initially targets prostate and breast cancer, aiding in disease tracking and clinical trial identification.
- Oncologists face challenges with data overload; CareIntellect aims to centralize patient information for easier management.
- Initial evaluations will occur at Tampa General Hospital and UT Southwestern Medical Center, with broader U.S. rollout in 2025.
Cloud-based tool makes data review more efficient.
GE HealthCare introduced “CareIntellect for Oncology,” a cloud-based tool designed to simplify the management of cancer patients’ data for care teams. The platform, expected to launch in the U.S. in 2025, aims to reduce the time clinicians spend on reviewing multi-modal data and streamline access...